Crestline Management LP lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 5.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,660,732 shares of the company’s stock after selling 300,000 shares during the period. Denali Therapeutics makes up 10.3% of Crestline Management LP’s holdings, making the stock its biggest position. […]

Related Keywords

United States , Stevee Krognes , Stifel Nicolaus , Vickil Sato , Nasdaq , Securities Exchange Commission , Principal Financial Group Inc , Eventide Asset Management , Goldman Sachs Group , Denali Therapeutics Inc , Norges Bank , Vanguard Group Inc , Crestline Management , Denali Therapeutics , Free Report , Financial Group , Asset Management , Get Free Report , Director Steve , Exchange Commission , Director Vicki , Therapeutics Inc , Visit Holdingschannel , Denali Therapeutics Daily ,